More on IVC
Data
Financials
Upcoming Events
News
Click line-items for a historical chart and %
| Condensed Consolidated Statement of Earnings | |
| Net sales | 268.15M |
| Cost of products sold | |
| Gross profit | 73.44M |
| Selling, general and administrative expense | 77.71M |
| Loss on debt extinguishment including debt finance charges and associated fees | |
| Charge related to restructuring activities | 508K |
| Interest expense | |
| Interest income | -79K |
| Earnings before income taxes | |
| Income taxes (benefit) | 4.43M |
| NET EARNINGS (LOSS) | -5.02M |
| DIVIDENDS DECLARED PER COMMON SHARE | 0.01 |
| Net earnings (loss) per share - basic | -0.15 |
| Weighted average shares outstanding - basic | 32.47M |
| Net earnings (loss) per share - assuming dilution | -0.15 |
| Weighted average shares outstanding - assuming dilution | 32.61M |
Entities mentioned with IVC
- Earnings | View Related Stories »
- 13G | View Related Stories »
- Dividend | View Related Stories »
- Trading Radar | View Related Stories »
- Morgan Stanley | View Related Stories »
- FDA | View Related Stories »
- Needham & Company | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
